Author: Piers Townley
-
Delivering the Less Survivable Cancers Taskforce petition to 10 Downing Street
Today we will deliver this petition to Government to demonstrate the weight of support behind it
-
Signalling pathway regulates Group 3 medulloblastomas
Recent research has found that a single signalling pathway regulates the growth and spread of Group 3 medulloblastomas
-
Cannabis-based medicinal products available by special prescription by 1 November
Yesterday the Home Secretary, Sajid Javid MP, announced cannabis-based medicinal products will be available through special prescription by 1 November to patients in England, Wales, Scotland and Northern Ireland
-
Launch of The Less Survivable Cancers Taskforce petition
Today sees the launch of the taskforce’s petition to commit NHS England to accept its five-year survival target
-
Doctors hail our brain tumour information for schools
The information we provide to help schools understand the needs of pupils diagnosed with a brain tumour has been praised by the British Medical Association
-
Policy blog: Day two at Conservative Party conference
Cameron Miller, Head of Policy & Public Affairs, reports from the 2018 Conservative Party annual conference
-
How can charities support a transformation of patient care through data?
Taz Cheema, our Business Analyst discusses how the patient community have led the development of our data-sharing initiative, BRIAN
-
Day one at Conservative Party conference
Cameron Miller, Head of Policy & Public Affairs, reports from the first day of the 2018 Conservative Party annual conference
-
NHS launch ‘NHS App’ in GP Practices across England
Yesterday NHS England began the roll-out of the new NHS App across six regions in England
-
The last day of the 2018 Labour Party conference
Cameron Miller, our Head of Policy & Public Affairs, reports from day three at the 2018 Labour Party annual conference
-
Day three at the 2018 Labour Party annual conference
Kielan Arblaster, our Policy & Public Affairs Assistant, reports from day three at the 2018 Labour Party annual conference
-
Day two at the 2018 Labour Party annual conference
Monday marked the Policy team speaking and engaging with MPs and delegates for the second day of the 2018 Labour Party annual conference. Kielan Arblaster reports
-
The Brain Tumour Charity at the Labour Party 2018 annual conference
Kielan Arblaster, our Policy & Public Affairs Assistant, reports from the conference
-
Tocagen completes recruitment for a Phase 3 clinical trial for high-grade gliomas
Tocagen, a clinical-stage, cancer-selective gene therapy company, recently announced that it has completed patient enrolment approximately three months ahead of schedule for their Toca 5 Phase 3 clinical trial
-
Your support was key to our Third Sector’s Charity of the Year 2018 award
At last night’s charity awards ceremony, we were crowned Charity of the Year 2018
-
Jack Morris CBE appointed chair of trustees
We are delighted to announce the appointment of Jack Morris CBE as our new chair of trustees
-
Launching our new gift in Wills campaign
Our powerful campaign, Leave Nothing Unsaid. Leave Nothing Undone, uses supporters’ stories to support and inspire others
-
Update from the Less Survivable Cancers Taskforce
Cameron Miller, Head of Policy & Public Affairs highlights our recommendations for the NHS long term plan
-
The Scotland Steering Committee at the Scottish Parliament
Cameron Miller, Head of Policy & Public Affairs, reports from the day’s proceedings
-
Halting the ‘immortality’ mechanism in glioblastomas
A team of researchers have identified a new therapeutic target in glioblastoma cells that could halt the aggressive growth of this tumour type
-
The Lewis Moody Foundation raises over £1million for people affected by brain tumours
The milestone galvanises the drive for support and research into brain tumours
-
Less Survivable Cancer Taskforce doubling survivable statement
Today sees the launch of the Less Survivable Cancer Taskforce’s campaign to double five-year survival for each of the six less survivable cancers
-
Scientists discover a chemical that can kill glioblastoma cells
Laboratory experiments show that a synthetic chemical is able to shut off glioblastoma cells’ energy source, leading to cell death
-
Developments for the European Medicines Agency
On Tuesday night, MPs in Westminster adopted an amendment to the Trade Bill which indicates support for the United Kingdom remaining in the regulatory framework of the European Medicines Agency (EMA)